Varghese G. Abraham

Varghese G. Abraham

Head of Clinical Development
Alladapt Immunotherapeutics


Varghese "Abe" Abraham currently serves as Head of Clinical Development at Alladapt Immunotherapeutics, a biotechnology company dedicated to developing effective and broadly applicable interventions for food allergy. In his current role, Abe is responsible for the development of strategy, design, and execution of Alladapt-sponsored clinical trials in the US and Europe. In collaboration with the Chief Medical Officer and colleagues, he develops and executes clinical development strategy through thoughtful collaboration with clinical operations, regulatory, clinical manufacturing, and other key functions with a singular focus on delivering new immunological therapeutic options for patients. 

Prior to his current role, Abe served as US Medical Team Lead (Senior Medical Director) in the Immunology and Ophthalmology unit at Genentech. In that role, Abe led medical strategy for Actemra in Rheumatoid Arthritis and Giant Cell Arteritis. He also supported earlier pipeline immunology molecules focused on Transplant-related Desensitization, Lupus Nephritis, Rheumatoid Arthritis, Systemic Sclerosis, and Systemic Lupus Erythematosus.

In addition to enjoying outdoor activities including fishing and hunting, Abe enjoys collecting vintage vinyl records across genres and learning about scotch. He has a passion for fostering diversity and inclusion within biotechnology and improving access to mentorship.